↓ Skip to main content

Drug supply shortage in Nigeria during COVID-19: efforts and challenges

Overview of attention for article published in Journal of Pharmaceutical Policy and Practice, January 2021
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (86th percentile)
  • Good Attention Score compared to outputs of the same age and source (75th percentile)

Mentioned by

news
1 news outlet
twitter
9 X users

Citations

dimensions_citation
20 Dimensions

Readers on

mendeley
128 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Drug supply shortage in Nigeria during COVID-19: efforts and challenges
Published in
Journal of Pharmaceutical Policy and Practice, January 2021
DOI 10.1186/s40545-021-00302-1
Pubmed ID
Authors

Edward Faiva, Hashim Talib Hashim, Mustafa Ahmed Ramadhan, Shingin Kovona Musa, John Bchara, Yahya Dheyaa Tuama, Yusuff Adebayo Adebisi, Mustafa Hayder Kadhim, Mohammad Yasir Essar, Shoaib Ahmad, Don Eliseo Lucero-Prisno

X Demographics

X Demographics

The data shown below were collected from the profiles of 9 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 128 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 128 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 13 10%
Researcher 9 7%
Student > Bachelor 9 7%
Unspecified 5 4%
Student > Doctoral Student 5 4%
Other 21 16%
Unknown 66 52%
Readers by discipline Count As %
Medicine and Dentistry 14 11%
Pharmacology, Toxicology and Pharmaceutical Science 10 8%
Nursing and Health Professions 7 5%
Social Sciences 7 5%
Unspecified 5 4%
Other 18 14%
Unknown 67 52%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 14. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 July 2021.
All research outputs
#2,598,512
of 25,245,273 outputs
Outputs from Journal of Pharmaceutical Policy and Practice
#69
of 495 outputs
Outputs of similar age
#70,002
of 519,697 outputs
Outputs of similar age from Journal of Pharmaceutical Policy and Practice
#8
of 28 outputs
Altmetric has tracked 25,245,273 research outputs across all sources so far. Compared to these this one has done well and is in the 89th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 495 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.1. This one has done well, scoring higher than 86% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 519,697 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 86% of its contemporaries.
We're also able to compare this research output to 28 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 75% of its contemporaries.